Zoledronate In the Prevention of Paget's Disease: Long Term Extension

Enrolling by invitationOBSERVATIONAL
Enrollment

287

Participants

Timeline

Start Date

April 5, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

May 31, 2027

Conditions
Paget Disease
Trial Locations (21)

3220

University Hospital Geelong, Geelong

6009

Sir Charles Gardner Hospital, Nedlands

10126

University of Turin, Turin

37007

University Hospital of Salamanca, Salamanca

50139

University Hospital of Careggi, Florence

53100

University of Siena, Siena

92019

University of Auckland, Auckland

NSW 2305

Royal Newcastle Centre, Newcastle

Unknown

University of Sydney, Sydney

University Hospital Saint-Luc, Brussels

St. Vincent's University Hospital, Dublin

Univeristy of Barcelona, Barcelona

QLD 4350

University of Queensland, Toowoomba

731 8022

The Princess Margaret Hospital, Christchurch

BC10 5NB

University of Bristol, Bristol

L7 8XP

University of Liverpool, Liverpool

SE1 9RT

Guy's and St Thomas Hospital NHS Trust, London

SE5 9RS

King's College Hospital, London

M13 9WL

Manchester Royal Infirmary, Manchester

EH4 2XU

NHS Lothian, Edinburgh

LL13 7TD

Wrexham Maelor Hospital, Wrexham

All Listed Sponsors
collaborator

European Research Council

OTHER

lead

University of Edinburgh

OTHER